Bio-Techne Corporation (TECH) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	1.2B	1.2B	1.2B	1.2B	1.1B
Cost of Revenue	416.0M	416.0M	429.4M	389.3M	366.9M
Gross Profit	799.1M	799.1M	790.3M	769.7M	769.8M
Operating Expenses
R&D Expense	94.8M	94.8M	99.5M	96.7M	92.5M
SG&A Expense	452.4M	452.4M	415.1M	393.3M	352.4M
General & Admin Expense	113.2M	452.4M	415.1M	393.3M	352.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	173.4M	73.1M	25.9M
Total Operating Expenses	547.2M	547.2M	688.0M	563.0M	470.9M
Cost and Expenses	963.1M	963.1M	1.1B	952.4M	837.8M
Operating Income (EBIT)	251.9M	251.9M	102.3M	206.7M	298.9M
Non-Operating
Interest Income	—	—	3.9M	3.3M	3.4M
Interest Expense	5.4M	5.4M	8.5M	15.7M	11.2M
Net Interest Income	(5.4M)	(5.4M)	(4.6M)	(12.4M)	(7.8M)
Other Non-Op Income/Expense	(11.2M)	(11.2M)	(3.8M)	(21.0M)	39.7M
Non-Operating Income (excl Interest)	5.8M	5.8M	(4.7M)	5.3M	(50.9M)
EBT (Pre-Tax Income)	240.7M	240.7M	98.5M	185.7M	338.7M
Income Tax Expense	58.8M	58.8M	25.1M	17.6M	53.2M
Bottom Line
Net Income	181.9M	181.9M	73.4M	168.1M	285.3M
Earnings from Cont. Ops	181.9M	181.9M	73.4M	168.1M	285.4M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	181.9M	181.9M	73.4M	168.1M	285.2M
Per Share
Basic EPS	$1.17	$1.17	$0.47	$1.07	$1.81
Diluted EPS	$1.16	$1.16	$0.46	$1.05	$1.76
Revenue Per Share	$7.79	$7.79	$7.74	$7.35	$7.23
Shares
Basic Shares Outstanding	156.0M	156.0M	157.5M	157.7M	157.2M
Diluted Shares Outstanding	157.0M	157.0M	159.7M	160.8M	161.9M
Profitability Metrics
EBITDA	343.4M	343.4M	216.9M	313.1M	457.1M
D&A	97.4M	97.4M	109.9M	111.7M	107.2M
EBIT	246.1M	246.1M	107.0M	201.4M	349.9M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026